FLUENCE ENERGY, INC. (FLNC) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ADMA Biologics, Inc. Investors of Upcoming Deadline

Bernstein Liebhard LLP reminded Fluence Energy investors of a November 27, 2026 deadline to seek lead-plaintiff status in a securities-fraud class action against Fluence Energy (NASDAQ: FLNC). The notice highlights litigation risk for the company, though it provides no allegations, damages figures, or operational updates.

Analysis

This is primarily a positioning and governance overhang rather than a new fundamental datapoint. For FLNC, the near-term transmission channel is higher perceived disclosure risk: investors typically demand a wider valuation discount until the lead-plaintiff process and the underlying allegations clarify whether prior guidance, project accounting, or customer/concentration disclosures could require a reset. The most relevant 1-3 month catalyst is not the filing deadline itself, but any incremental company disclosure, auditor commentary, restatement risk, or reduction in backlog-to-revenue conversion expectations.

The non-obvious exposure is FLNC's cost of capital. Grid-scale storage projects are long-duration, working-capital-intensive contracts; a lower equity currency and heightened counterparty scrutiny can weaken bid discipline or increase financing friction even absent direct damages. That could create share gains for better-capitalized storage integrators, particularly TSLA, while pure-play peers such as STEM may suffer sentiment contagion despite having distinct operating issues. Consensus may overreact to the procedural headline if no new adverse fact emerges, but the correct response is to avoid treating a technical rebound as a cleared fundamental risk until management re-establishes confidence in margins, cash conversion, and backlog quality.

A durable recovery case over 6-18 months requires independently verifiable evidence that project execution is normalizing: stable gross-margin guidance, no deterioration in receivables or contract assets, and backlog converting without unusual concessions. The bearish thesis is falsified by clean quarterly disclosures and reaffirmed or raised full-year cash-flow expectations; it is reinforced by any guidance cut, customer dispute, auditor turnover, or material increase in provisions. Given the absence of allegations detail and financial-loss estimates in the available information, this is not sufficient alone to justify a directional short.

Key Decisions for Investors

• Maintain FLNC as underweight/watch-list rather than initiate a fresh short solely on this notice; reassess after the next earnings release for contract-asset growth, receivables aging, gross-margin guidance, and cash-flow conversion. A clean print with reaffirmed guidance would remove the near-term catalyst for a litigation-driven short.
• For existing FLNC long exposure, reduce gross exposure or hedge through the next reporting event using a defined-risk put spread rather than outright stock liquidation; use a 2-4 month maturity and size the hedge to event risk, since procedural litigation headlines can reverse sharply without new evidence.
• Consider a 1-3 month relative-value screen: long TSLA versus short FLNC only if FLNC underperforms after a fundamental disclosure and TSLA's energy-storage deployment/margin trajectory remains intact. The thesis is capital-quality and execution differentiation, not broad battery-storage demand; close if FLNC reaffirms cash-flow guidance or the spread widens materially without new company-specific evidence.
• Do not use STEM as a clean hedge proxy for FLNC. Any sympathy selloff may create a tactical opportunity only after confirming STEM-specific liquidity and guidance risk, which can dominate sector sentiment.